{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:54:38Z","timestamp":1781859278161,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA059788"],"award-info":[{"award-number":["R21DA059788"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS129478"],"award-info":[{"award-number":["R21NS129478"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bbrc.2026.153409","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:47:08Z","timestamp":1770252428000},"page":"153409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lead optimization of AMS-17 identifies AMS-4 as a modulator of inflammasome-driven cocaine-associated neuroinflammation"],"prefix":"10.1016","volume":"806","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9382-0603","authenticated-orcid":false,"given":"Seema","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1237-5558","authenticated-orcid":false,"given":"Aitizaz UL","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiola","family":"Oladapo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis O.","family":"Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Buch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9091-7319","authenticated-orcid":false,"given":"Amol","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0386-5611","authenticated-orcid":false,"given":"Palsamy","family":"Periyasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.153409_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.8049","article-title":"Comparison of treatments for cocaine use disorder among adults: a systematic review and meta-analysis","volume":"4","author":"Bentzley","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.bbrc.2026.153409_bib2","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1186\/s12889-024-19142-0","article-title":"Burden of drug use disorders in the United States from 1990 to 2021 and its projection until 2035: results from the GBD study","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.bbrc.2026.153409_bib3","series-title":"Substance Abuse and Rehabilitation","first-page":"25","article-title":"Cocaine use disorder (CUD): current clinical perspectives","author":"Schwartz","year":"2022"},{"key":"10.1016\/j.bbrc.2026.153409_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1357422","article-title":"Neurovascular effects of cocaine: relevance to addiction","volume":"15","author":"Clare","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153409_bib5","series-title":"Drug Overdose Deaths in the United States, 2003\u20132023","author":"Garnett","year":"2024"},{"key":"10.1016\/j.bbrc.2026.153409_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.134951","article-title":"Cocaine self-administration differentially activates microglia in the mouse brain","volume":"728","author":"Burkovetskaya","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2026.153409_bib7","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbrc.2026.153409_bib8","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3390\/jpm11100963","article-title":"NLRP3 inflammasome is involved in cocaine-mediated potentiation on behavioral changes in CX3CR1-deficient mice","volume":"11","author":"Guo","year":"2021","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.bbrc.2026.153409_bib9","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s12035-020-02184-x","article-title":"NLRP3 inflammasome blockade reduces cocaine-induced microglial activation and neuroinflammation","volume":"58","author":"Chivero","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbrc.2026.153409_bib10","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3390\/biom13060922","article-title":"Microglia NLRP3 inflammasome and neuroimmune signaling in substance use disorders","volume":"13","author":"Guo","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrc.2026.153409_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11100963","article-title":"NLRP3 inflammasome is involved in cocaine-mediated potentiation on behavioral changes in CX3CR1-Deficient mice","volume":"11","author":"Guo","year":"2021","journal-title":"J. Personalized Med."},{"key":"10.1016\/j.bbrc.2026.153409_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11071800","article-title":"Cocaine regulates NLRP3 inflammasome activity and CRF signaling in a Region- and sex-dependent manner in rat brain","volume":"11","author":"Cheng","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrc.2026.153409_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116261","article-title":"Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome in systemic lupus erythematosus","volume":"172","author":"Wu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbrc.2026.153409_bib14","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1021\/acschembio.1c00218","article-title":"A probe for NLRP3 inflammasome inhibitor MCC950 identifies carbonic anhydrase 2 as a novel target","volume":"16","author":"Kennedy","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbrc.2026.153409_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27196213","article-title":"A selective review and virtual screening analysis of natural product inhibitors of the NLRP3 inflammasome","volume":"27","author":"El-Sayed","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2026.153409_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114553","article-title":"Drug discovery from natural products\u2013old problems and novel solutions for the treatment of neurodegenerative diseases","volume":"210","author":"Maitra","year":"2022","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.bbrc.2026.153409_bib17","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1021\/acs.jmedchem.5b01009","article-title":"Can invalid bioactives undermine natural product-based drug discovery?","volume":"59","author":"Bisson","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.153409_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116645","article-title":"Targeting NLRP3 signaling by a novel-designed sulfonylurea compound for inhibition of microglial inflammation","volume":"58","author":"Zhang","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.153409_bib19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.bbrc.2026.153409_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12987-025-00665-6","article-title":"Targeting NLRP3 signaling with a novel sulfonylurea compound for the treatment of vascular cognitive impairment and dementia","volume":"22","author":"Akif","year":"2025","journal-title":"Fluids Barriers CNS"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26001737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26001737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:20:24Z","timestamp":1781857224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26001737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":20,"alternative-id":["S0006291X26001737"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153409","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lead optimization of AMS-17 identifies AMS-4 as a modulator of inflammasome-driven cocaine-associated neuroinflammation","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"153409"}}